SMTI vs. AVNS, ZJYL, INGN, LAKE, CLGN, NTRB, APT, MLSS, RBOT, and COCH
Should you be buying Sanara MedTech stock or one of its competitors? The main competitors of Sanara MedTech include Avanos Medical (AVNS), Jin Medical International (ZJYL), Inogen (INGN), Lakeland Industries (LAKE), CollPlant Biotechnologies (CLGN), Nutriband (NTRB), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Vicarious Surgical (RBOT), and Envoy Medical (COCH). These companies are all part of the "surgical appliances & supplies" industry.
Sanara MedTech (NASDAQ:SMTI) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.
Sanara MedTech presently has a consensus target price of $44.00, suggesting a potential upside of 41.39%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities analysts clearly believe Sanara MedTech is more favorable than Avanos Medical.
Sanara MedTech has a beta of 1.67, suggesting that its share price is 67% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.
Avanos Medical received 65 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 54.97% of users gave Avanos Medical an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote.
8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 95.2% of Avanos Medical shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by company insiders. Comparatively, 3.9% of Avanos Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Avanos Medical had 12 more articles in the media than Sanara MedTech. MarketBeat recorded 12 mentions for Avanos Medical and 0 mentions for Sanara MedTech. Avanos Medical's average media sentiment score of 0.13 beat Sanara MedTech's score of 0.00 indicating that Avanos Medical is being referred to more favorably in the news media.
Sanara MedTech has a net margin of -7.19% compared to Avanos Medical's net margin of -9.15%. Avanos Medical's return on equity of 4.10% beat Sanara MedTech's return on equity.
Sanara MedTech has higher earnings, but lower revenue than Avanos Medical. Sanara MedTech is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Sanara MedTech and Avanos Medical tied by winning 9 of the 18 factors compared between the two stocks.
Get Sanara MedTech News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMTI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sanara MedTech Competitors List
Related Companies and Tools
